Wednesday, September 18, 2024 10:44:31 AM
Recent VVOS News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:05:34 PM
- Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies • GlobeNewswire Inc. • 02/05/2026 01:45:00 PM
- Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds • GlobeNewswire Inc. • 01/20/2026 10:31:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 09:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 09:05:42 PM
- Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds • GlobeNewswire Inc. • 01/16/2026 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/14/2026 09:05:32 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/08/2026 05:15:06 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/02/2026 09:44:43 PM
- Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan • GlobeNewswire Inc. • 12/16/2025 01:45:00 PM
- Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST • GlobeNewswire Inc. • 12/15/2025 10:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:12:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 09:45:04 PM
- Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 • GlobeNewswire Inc. • 11/19/2025 09:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 09:06:19 PM
- Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call • GlobeNewswire Inc. • 11/19/2025 01:30:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 09:58:16 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/24/2025 09:22:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 09:20:50 PM
- Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment • GlobeNewswire Inc. • 09/17/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2025 08:52:50 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/12/2025 08:50:44 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
